Literature DB >> 19355823

Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.

Antonia Rego-Iraeta1, Luisa F Pérez-Méndez, Beatriz Mantinan, Ricardo V Garcia-Mayor.   

Abstract

BACKGROUND: Thyroid cancer incidence is increasing throughout the world. Most studies attribute this rise entirely to the increase in papillary carcinoma, the most common thyroid malignancy in iodine-sufficient areas. A variety of nonetiological factors such as changes in clinical practice may affect the incidence of thyroid cancer and some researchers have suggested that this rise is only apparent due to an increase in diagnostic activity. Since data on the epidemiology of thyroid cancer in Spain are scarce, the main goal of this study was to analyze changes in thyroid cancer presentation, incidence, and prevalence in Vigo (northwestern Spain) between 1978 and 2001, and to investigate the relationship between the incidence rates and trends in tumor size and thyroid surgery.
METHODS: In this descriptive epidemiologic study, an analysis was carried out on new thyroid cancer cases obtained from the Pathology Registry of the University Hospital of Vigo (500,000 inhabitants). Trends in age, sex, thyroid surgery, histological type, tumor size, and incidence rates were calculated. The prevalence of thyroid cancer was determined in three cross-sectional surveys.
RESULTS: The rate of population undergoing thyroid surgery significantly increased over time. Out of 322 new primary thyroid cancers, papillary thyroid cancer (PTC) was the predominant type (76%). The age-standardized incidence rate shows a significant increase in females: 1.56 per 100,000 year (1978 to 1985) to 3.83 (1986 to 1993) and 8.23 (1994 to 2001); and in males: 0.33, 1.19, and 2.65, respectively. PTC was mainly responsible for this pattern and was the result of both the increase in micropapillary thyroid carcinoma (MPTC) incidence and in PTC measuring more than 1 cm. Besides MPTC cases, no significant variations were observed in tumor size over time.
CONCLUSIONS: In northwestern Spain, the incidence of thyroid cancer is increasing. These data should be taken into account when planning health resources for these patients. Our results may reflect the contribution that other factors, besides increased diagnostic activity, have made to the rise in thyroid cancer incidence in our region. Additional studies are needed to explain the rise in PTC incidence throughout the world and to search for potential risk factors that are currently unrecognized.

Entities:  

Mesh:

Year:  2009        PMID: 19355823     DOI: 10.1089/thy.2008.0210

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  41 in total

1.  Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis.

Authors:  Richard J Q McNally; Karen Blakey; Peter W James; Basilio Gomez Pozo; Nermine O Basta; Juliet Hale
Journal:  Eur J Epidemiol       Date:  2012-07-04       Impact factor: 8.082

2.  Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006.

Authors:  Oladejo Olaleye; Udeme Ekrikpo; Ram Moorthy; Owen Lyne; Jill Wiseberg; Myles Black; David Mitchell
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-12       Impact factor: 2.503

3.  Prevalence of Cancer in Patients with Thyroid Nodules in the Island of Cyprus: Predictive Value of Ultrasound Features and Thyroid Autoimmune Status.

Authors:  Irini S Hadjisavva; Roberto Dina; Michael A Talias; Panayiotis A Economides
Journal:  Eur Thyroid J       Date:  2015-05-30

4.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

5.  Current management of papillary thyroid microcarcinoma in Canada.

Authors:  Mazin Merdad; Antoine Eskander; John De Almeida; Jeremy Freeman; Lorne Rotstein; Shereen Ezzat; Anna M Sawka; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-08-14

6.  Clinicopathological features of thyroid cancer in the elderly compared to younger counterparts: single-center experience.

Authors:  F D Dellal; D Özdemir; A A Tam; H Baser; H Tatli Dogan; O Parlak; R Ersoy; B Cakir
Journal:  J Endocrinol Invest       Date:  2016-11-24       Impact factor: 4.256

7.  Intra- and postoperative complications in 137 cases of giant thyroid gland tumor.

Authors:  Wei DU; Shan-Ting Liu; Peng Li; Li-Yan Sun; Ming Zhao; Jin-Xing Qi; Rui-Hua Luo; Lu Feng; Li-Yuan Dai; Meng Cui; Chang-Fu Sun; Fa-Yu Liu
Journal:  Oncol Lett       Date:  2012-08-06       Impact factor: 2.967

Review 8.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

9.  Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype.

Authors:  J H Shulin; J Aizhen; S M Kuo; W B Tan; K Y Ngiam; R Parameswaran
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

10.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.

Authors:  Bo Youn Cho; Hoon Sung Choi; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; Kyung Won Kim; Ka Hee Yi; June-Key Chung; Yeo-Kyu Youn; Nam Han Cho; Do Joon Park; Chang-Soon Koh
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.